Take a ride on the Evotec “Data-driven R&D Autobahn to Cures”
5 virtual sessions over 5 days discussing:
How Evotec is using data and science across treatment modalities to accelerate innovation in the area of precision medicine to deliver enhanced speed, lower cost, and predictive efficacy
Our efforts in AI/ML in the design and development of both small molecules and antibodies, the importance of biomarker development, targeting RNA, and our approaches to target validation
Each session will take c. 45 min including a Q&A session. Please note you will need to register for each session individually.
PROGRAM
Drug discovery in the Evotec multiverse: Knowledge-driven integrated R&D
Adam Davenport | EVP, Head of Global Molecular Discovery
Tim James | VP, Head of Data Science
Christophe Boldron | VP, Head of Medicinal Chemistry
Click here to register.
Day 2 | Tuesday, 7 December
The importance of precision medicine: How biomarkers optimize translation from bench to bedside and back
Elizabeth van der Kam | SVP, Translational Biomarkers
Christoph Schaab | SVP, Head of Proteomics and Metabolomics
Click here to register.
Day 3 | Wednesday, 8 December
The early bird catches the helix: Expanding the druggable target space to RNA
Steffen Grimm | Group Leader, Hit ID and Biophysics
Hilary Brooks | Senior Research Scientist, In Vitro Pharmacology
Click here to register.
Day 4 | Thursday, 9 December
Do firefighters cause fires? Establishing real disease associations through target validation
Hauke Cornils | VP, Early Discovery
Susan Boyce | VP, Head of Neuropharmacology
Click here to register.
Day 5 | Friday, 10 December
Translate your idea into product: AI-driven antibody discovery at Evotec
Barbara Bachler-Konetzki | Group Leader, In Vitro Pharmacology
Randal Ketchem | SVP, Discovery and Molecular Design
Maria Pilla | EVP, Global Head of Preclinical Development
Click here to register.
All sessions will be moderated by Christophe Muller, EVP, Global Head of Business Development and
Ryan Brady, EVP, Head of Business Development.